Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Health Canada approves Afinitor for advanced breast cancer

Jan. 17, 2013

FDA grants priority review for afatinib in NSCLC with an EGFR mutation

Jan. 17, 2013

Novartis patent reveals p53/Mdm2 interaction inhibitors

Jan. 17, 2013

ATR kinase inhibitors patented by Vertex Pharmaceuticals

Jan. 17, 2013

Zenobia Therapeutics develops novel LRRK2 inhibitors

Jan. 16, 2013

Novel GnRH receptor antagonists emerge from Bayer R&D

Jan. 16, 2013

FDA accepts for filing Tarceva sNDA

Jan. 16, 2013

Detection of endometrial and ovarian cancers through DNA screening of Pap smears

Jan. 16, 2013

Argos Therapeutics enrolls first patients in phase III ADAPT study

Jan. 16, 2013

Vertex Pharmaceuticals synthesizes new protein kinase inhibitors

Jan. 16, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...